Searched for
CONCORD BIOTECH
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities gained on Monday as cooling oil prices and positive global cues lifted sentiment. Sensex rose 564 points to 74,859, while N...- Samir Arora-backed Helios Mid Cap Fund exits Dixon Technologies, 2 others; adds 7 stocksHelios Mid Cap Fund, backed by Samir Arora, exited Dixon Technologies, Aadhar Housing Finance and Black Box in August. The fund added eight...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended sharply lower on Thursday as expiry-day volatility intensified after the first monthly expiry under the Closing Aucti...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Market Trading Guide: Hindustan Copper among 2 stock recommendations for TuesdayAnalysts recommend Hindustan Copper and Concord Biotech after both stocks broke key resistance levels with strong price action, volume and ...
- Two Trades for Today: A capital market player for a 6.45% rise, a mid-cap pharma stock for an almost 6% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Stock Radar: Concord Biotech stock showing signs of rebound after falling over 20% from highs; time to buy?Concord Biotech stock shows a breakout from a seven-month consolidation phase. Experts suggest buying the stock for a target above 1,500 le...
- Ahead of Market: 10 things that will decide stock market action on MondayThe Indian stock market rallied around 3% over the last week, recouping its early losses despite global volatility. Analysts expect the mar...
- Blue Jet Healthcare among 4 stocks flashing bullish signals, hinting at a possible uptrendOn July 29, four stocks in the Nifty500 appeared on the White Marubozu bullish scanner, according to StockEdge's technical scan data. The W...
- Kaynes Technology among 9 stocks showing bullish RSI upswingNine stocks in the Nifty500 pack that gained over 5% featured in the RSI Trending Up scan on July 29 after showing improving momentum. The ...
- Positive Breakout: These 8 stocks cross above their 200 DMAsAs long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- Concord Biotech shares list at a healthy premium. What should investors do?Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech shares list at 21% premium over IPO priceConcord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO opens. Should you subscribe to the issue?Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client ...
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
- Concord Biotech files DRHP with Sebi for Rs 2,000-2,500 cr IPOSources told ET that the IPO would be of ₹2000 crore - ₹2500 crore size.The issue with a face value of ₹1 per equity share is a complete of...
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...
Load More
